دورية أكاديمية

Real-world experience on tolerability and safety of relugolix combined with androgen signaling inhibitors in patients with advanced prostate cancer.

التفاصيل البيبلوغرافية
العنوان: Real-world experience on tolerability and safety of relugolix combined with androgen signaling inhibitors in patients with advanced prostate cancer.
المؤلفون: Guan, Jian, Adroja, Shubham, Ajmal, Zainub, Gao, Yuan, Spetsieris, Nicholas, Hu, Siqi, Satkunasivam, Raj, Brooks, Michael A, Farach, Andrew M., Butler, E. Brian, Miles, Brian, Efstathiou, Eleni
المصدر: Journal of Clinical Oncology; 2024 Supplement 4, Vol. 42, p85-85, 235p
قاعدة البيانات: Supplemental Index
الوصف
تدمد:0732183X
DOI:10.1200/JCO.2024.42.4_suppl.85